• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Are trials of intravascular infusions of autologous mesenchymal stem cells in patients with multiple system atrophy currently justified, and are they effective?

作者信息

Low Phillip A, Gilman Sid

出版信息

Ann Neurol. 2012 Jul;72(1):4-5. doi: 10.1002/ana.23655.

DOI:10.1002/ana.23655
PMID:22829263
Abstract
摘要

相似文献

1
Are trials of intravascular infusions of autologous mesenchymal stem cells in patients with multiple system atrophy currently justified, and are they effective?目前，对多系统萎缩患者进行自体间充质干细胞血管内输注试验是否合理，是否有效？
Ann Neurol. 2012 Jul;72(1):4-5. doi: 10.1002/ana.23655.
2
Are trials of intravascular infusions of autologous mesenchymal stem cells in patients with multiple system atrophy currently justified, and are they effective?目前，对多系统萎缩患者进行自体间充质干细胞血管内输注试验是否合理，以及这些试验是否有效？
Clin Pharmacol Ther. 2008 May;83(5):663-5. doi: 10.1038/sj.clpt.6100454.
3
A randomized trial of mesenchymal stem cells in multiple system atrophy.多系统萎缩中骨髓间充质干细胞的随机试验。
Ann Neurol. 2012 Jul;72(1):32-40. doi: 10.1002/ana.23612.
4
Preliminary report of multiple cell therapy for patients with multiple system atrophy.多系统萎缩患者的多细胞治疗初步报告。
Cell Transplant. 2013;22 Suppl 1:S93-9. doi: 10.3727/096368913X672145. Epub 2013 Aug 29.
5
Can the therapeutic advantages of allogenic umbilical cord blood-derived stem cells and autologous bone marrow-derived mesenchymal stem cells be combined and synergized?异体脐带血来源的干细胞和自体骨髓来源的间充质干细胞的治疗优势能否合并并产生协同作用？
ASAIO J. 2006 Nov-Dec;52(6):611-3. doi: 10.1097/01.mat.0000235330.02549.78.
6
Comment: Autologous mesenchymal stem cells: Hope for patients with multiple system atrophy?评论：自体间充质干细胞：是多系统萎缩患者的希望吗？
Neurology. 2019 Jul 2;93(1):25. doi: 10.1212/WNL.0000000000007721. Epub 2019 May 31.
7
Neuroprotective effect of human mesenchymal stem cells in an animal model of double toxin-induced multiple system atrophy parkinsonism.人骨髓间充质干细胞在双毒素诱导的多系统萎缩帕金森病动物模型中的神经保护作用。
Cell Transplant. 2011;20(6):827-35. doi: 10.3727/096368910X540630. Epub 2010 Nov 5.
8
Autologous bone marrow mesenchymal stem cells implantation for cartilage defects: two cases report.自体骨髓间充质干细胞植入治疗软骨缺损：两例报告
J Med Assoc Thai. 2011 Mar;94(3):395-400.
9
[Treatment of early avascular necrosis of femoral head by core decompression combined with autologous bone marrow mesenchymal stem cells transplantation].[髓芯减压联合自体骨髓间充质干细胞移植治疗早期股骨头缺血性坏死]
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2010 Jun;24(6):739-43.
10
Safety of autologous bone marrow-derived mesenchymal stem cell transplantation for cartilage repair in 41 patients with 45 joints followed for up to 11 years and 5 months.41 例 45 个关节患者行自体骨髓间充质干细胞移植修复软骨，随访时间长达 11 年 5 个月，安全性评估。
J Tissue Eng Regen Med. 2011 Feb;5(2):146-50. doi: 10.1002/term.299.

引用本文的文献

1
Multiple system atrophy: an update and emerging directions of biomarkers and clinical trials.多系统萎缩：生物标志物与临床试验的最新进展及新方向
J Neurol. 2024 May;271(5):2324-2344. doi: 10.1007/s00415-024-12269-5. Epub 2024 Mar 14.
2
Stem Cell Therapies in Movement Disorders: Lessons from Clinical Trials.运动障碍的干细胞疗法：临床试验的经验教训
Biomedicines. 2023 Feb 9;11(2):505. doi: 10.3390/biomedicines11020505.
3
Phase I Trial of Intra-arterial Administration of Autologous Bone Marrow-Derived Mesenchymal Stem Cells in Patients with Multiple System Atrophy.
自体骨髓间充质干细胞动脉内给药治疗多系统萎缩患者的I期试验
Stem Cells Int. 2021 Oct 19;2021:9886877. doi: 10.1155/2021/9886877. eCollection 2021.
4
Intrathecal administration of autologous mesenchymal stem cells in multiple system atrophy.鞘内注射自体间充质干细胞治疗多系统萎缩。
Neurology. 2019 Jul 2;93(1):e77-e87. doi: 10.1212/WNL.0000000000007720. Epub 2019 May 31.
5
Novel therapeutic approaches in multiple system atrophy.多系统萎缩的新型治疗方法。
Clin Auton Res. 2015 Feb;25(1):37-45. doi: 10.1007/s10286-014-0249-7. Epub 2014 Jun 14.
6
Towards translational therapies for multiple system atrophy.迈向多系统萎缩的转化疗法。
Prog Neurobiol. 2014 Jul;118:19-35. doi: 10.1016/j.pneurobio.2014.02.007. Epub 2014 Mar 2.
7
Efficacy and safety of rifampicin for multiple system atrophy: a randomised, double-blind, placebo-controlled trial.利福平治疗多系统萎缩的疗效和安全性：一项随机、双盲、安慰剂对照试验。
Lancet Neurol. 2014 Mar;13(3):268-75. doi: 10.1016/S1474-4422(13)70301-6. Epub 2014 Feb 5.